Clinical Trial Update: Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein [Phase 4]

View source ↗

Summary

Phase 4 trial comparing full-dose versus half-dose intravenous fluorescein for fluorescein angiography; status suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fluorescein Angiography

Drugs mentioned

• intravenous fluorescein (fluorescein)

Snippet

Sponsor: Kresge Eye Institute | Conditions: Fluorescein Angiography | Phase 4 | Status: SUSPENDED